Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive multiple sclerosis (PPMS), revealing that it was at least as effective as its ...
MindsEye studio Build a Rocket Boy have been sued by unionised staff who alleged the installation of surveillance software ...
Because many password generators aren't as random as they seem, I built an improved one in Excel—and I'll show you exactly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results